BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7769864)

  • 1. [Lipoprotein(a): its concentrations in children with insulin-dependent diabetes mellitus].
    Ferrer I; Llopart R; Moyano D; Paviá C; Farré C; Ordónez J
    Med Clin (Barc); 1995 Apr; 104(15):565-7. PubMed ID: 7769864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The relationship of lipoprotein(a) to metabolic control in infantile-juvenile diabetes mellitus].
    Llopart Gil R; Ferrer Codina I; Artuch Iriberri R; Moyano Ontiveros D; Pavía Sesma C; Ordóñez Llanos J
    An Esp Pediatr; 1996 Jan; 44(1):7-10. PubMed ID: 8849067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between lipoprotein(a) and other risk factors for cardiovascular disease and diabetes in Cherokee Indians: the Cherokee Diabetes Study.
    Wang W; Lee ET; Alaupovic P; Blackett P; Blevins KS
    Ann Epidemiol; 2005 May; 15(5):390-7. PubMed ID: 15840553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lipoprotein(a) concentrations in type I diabetes mellitus].
    Figueroa AC; Gil RL; Pedragós AC; González GC; Marqués RB; Díaz JA; Llanos JO; Pérez AP
    Rev Clin Esp; 1996 Feb; 196(2):87-91. PubMed ID: 8685494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved metabolic control does not change plasma lipoprotein(a) levels in adolescents with type 1 diabetes mellitus.
    Torres-Tamayo M; Perez-Pasten LE; Barron-Uribe C; Hermida-Gutierrez I; Zamora-Gonzalez J; Cardoso-Saldaña G; Posadas-Romero C
    Arch Med Res; 1998; 29(4):307-12. PubMed ID: 9887548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of selected risk factors of atherosclerosis in children with type 1 diabetes mellitus and hypercholesterolemia].
    Muchacka-Bianga M; Deja G; Jarosz-Chobot P; Małecka-Tendera E; Kalina M; Grychtoł M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):25-30. PubMed ID: 16704858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein(a) concentrations in patients with type 2 diabetes mellitus without cardiovascular disease: relationship to metabolic parameters and diabetic complications.
    Tarkun I; Cetinarslan B; Cantürk Z
    Nutr Metab Cardiovasc Dis; 2002 Jun; 12(3):127-31. PubMed ID: 12325469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein (a) and other risk factors in children with insulin-dependent diabetes mellitus and children without diabetes.
    Martinez MT; Ramos O; Carretero N; Calvillan M; Gutierrez-Lopez MD; Cuesta P; Serrano-Rios M
    Diabete Metab; 1994; 20(6):522-5. PubMed ID: 7713274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
    Gaeta G; Cuomo S; Capozzi G; Foglia MC; Barra S; Madrid A; Stornaiuolo V; Trevisan M
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):492-6. PubMed ID: 17962002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin A, retinol binding protein and lipids in type 1 diabetes mellitus.
    Baena RM; Campoy C; Bayés R; Blanca E; Fernández JM; Molina-Font JA
    Eur J Clin Nutr; 2002 Jan; 56(1):44-50. PubMed ID: 11840179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating acylated and total ghrelin and galanin in children with insulin-treated type 1 diabetes: relationship to insulin therapy, metabolic control and pubertal development.
    Celi F; Bini V; Papi F; Santilli E; Ferretti A; Mencacci M; Berioli MG; De Giorgi G; Falorni A
    Clin Endocrinol (Oxf); 2005 Aug; 63(2):139-45. PubMed ID: 16060906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lipoprotein (a) and diabetes mellitus].
    Ziegler O; Guerci B; Candiloros H; Drouin P
    Diabete Metab; 1995 Apr; 21(2):127-38. PubMed ID: 7621973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between lipoprotein(a) and the complications of diabetes mellitus.
    Koschinsky ML; Marcovina SM
    Acta Diabetol; 2003 Jun; 40(2):65-76. PubMed ID: 12861403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current state of metabolic control achieved in a New Zealand diabetes clinic.
    Dunn PJ
    N Z Med J; 1996 Mar; 109(1018):98-101. PubMed ID: 8606845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of lipid and lipoprotein(a) to ischaemic stroke.
    Misirli H; Somay G; Ozbal N; Yaşar Erenoğlu N
    J Clin Neurosci; 2002 Mar; 9(2):127-32. PubMed ID: 11922698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lipoprotein (a) and other risk factors in Chilean children with type I diabetes mellitus].
    Martínez MT; Pérez F; Calvillán M; Gutierrez-López MD; Serrano-Ríos M
    Rev Med Chil; 1994 Oct; 122(10):1115-9. PubMed ID: 7659875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein (a) in patients with psoriasis: associations with lipid profiles and disease severity.
    Pietrzak A; Kadzielewski J; Janowski K; Roliński J; Krasowska D; Chodorowska G; Paszkowski T; Kapeć E; Jastrzebska I; Tabarkiewicz J; Lotti T
    Int J Dermatol; 2009 Apr; 48(4):379-87. PubMed ID: 19335423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of relationship between Lp(a) particle levels and albumin excretion rate in type 1 diabetic patients.
    Guerci B; Igau B; Ziegler O; Crea T; Fruchart JC; Drouin P; Fievet C
    Diabete Metab; 1994; 20(6):526-31. PubMed ID: 7713275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lp(a) serum concentrations in diabetes mellitus].
    Murakami J; Kumasaka K; Kawano K; Murakami T; Hayashi Y; Arakawa Y
    Rinsho Byori; 1994 Dec; 42(12):1273-8. PubMed ID: 7869592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.